Plant ID: NPO11228
Plant Latin Name: Fritillaria pallidiflora
Taxonomy Genus: Fritillaria
Taxonomy Family: Liliaceae
NCBI TaxonomyDB:
152091
Plant-of-the-World-Online:
535262-1
Antispasmodic; Antitussive; Expectorant; Febrifuge; Pectoral
Kazakhstan; China
ADORA3; ADORA2A; ADORA1; | |
CDA; RECQL; TK1; ADK; PNP; | |
STAT6; | |
ABCB1; | |
SLC28A2; SLC28A1; SLC28A3; | |
LMNA; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCB1 | P-glycoprotein 1 | P08183 | CHEMBL4302 |
Enzyme_unclassified | CDA | Cytidine deaminase | P32320 | CHEMBL4502 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | TK1 | Thymidine kinase, cytosolic | P04183 | CHEMBL2883 |
Enzyme_unclassified | ADK | Adenosine kinase | P55263 | CHEMBL3589 |
Enzyme_unclassified | PNP | Purine nucleoside phosphorylase | P00491 | CHEMBL4338 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
SLC superfamily of solute carriers | SLC28A2 | Sodium/nucleoside cotransporter 2 | O43868 | CHEMBL5780 |
SLC superfamily of solute carriers | SLC28A1 | Sodium/nucleoside cotransporter 1 | O00337 | CHEMBL5551 |
SLC superfamily of solute carriers | SLC28A3 | Solute carrier family 28 member 3 | Q9HAS3 | CHEMBL5707 |
Small molecule receptor (family A GPCR) | ADORA3 | Adenosine A3 receptor | P0DMS8 | CHEMBL256 |
Small molecule receptor (family A GPCR) | ADORA2A | Adenosine A2a receptor | P29274 | CHEMBL251 |
Small molecule receptor (family A GPCR) | ADORA1 | Adenosine A1 receptor | P30542 | CHEMBL226 |
Transcription Factor | STAT6 | Signal transducer and activator of transcription 6 | P42226 | CHEMBL5401 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0060089; molecular transducer activity | GO:0001609; G-protein coupled adenosine receptor activity | 1.629E-08 | 6.604E-05 | ADORA1, ADORA2A, ADORA3 |
BP | GO:0009987; cellular process | GO:0001973; adenosine receptor signaling pathway | 3.905E-08 | 1.063E-04 | ADORA1, ADORA2A, ADORA3 |
BP | GO:0051179; localization | GO:0015860; purine nucleoside transmembrane transport | 6.433E-07 | 1.077E-03 | SLC28A2, SLC28A3 |
MF | GO:0005215; transporter activity | GO:0015389; pyrimidine- and adenine-specific:sodium symporter activity | 6.433E-07 | 1.077E-03 | SLC28A1, SLC28A3 |
MF | GO:0005215; transporter activity | GO:0015211; purine nucleoside transmembrane transporter activity | 6.433E-07 | 1.077E-03 | SLC28A2, SLC28A3 |
BP | GO:0051179; localization | GO:1904823; purine nucleobase transmembrane transport | 1.929E-06 | 2.100E-03 | SLC28A1, SLC28A3 |
BP | GO:0051179; localization | GO:0015855; pyrimidine nucleobase transport | 1.929E-06 | 2.100E-03 | SLC28A1, SLC28A3 |
CC | GO:0044464; cell part | GO:0099056; integral component of presynaptic membrane | 1.929E-06 | 2.100E-03 | ADORA1, ADORA2A |
BP | GO:0008152; metabolic process | GO:0009165; nucleotide biosynthetic process | 1.667E-05 | 1.171E-02 | ADK, ADORA2A, PNP, TK1 |
CC | GO:0044456; synapse part | GO:0099055; integral component of postsynaptic membrane | 2.308E-05 | 1.323E-02 | ADORA1, ADORA2A |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 4.225E-05 | 2.140E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 4.991E-05 | 2.415E-02 | SMN1, SMN2 |
MF | GO:0003824; catalytic activity | GO:0019206; nucleoside kinase activity | 5.820E-05 | 2.640E-02 | ADK, TK1 |
CC | GO:0044464; cell part | GO:0030673; axolemma | 7.667E-05 | 3.150E-02 | ADORA1, ADORA2A |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09104 Nucleotide metabolism | hsa00240 | Pyrimidine metabolism | 7.492E-05 | 2.098E-03 | CDA, PNP, TK1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 6.084E-04 | 8.518E-03 | CDA, TK1 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 1.288E-03 | 1.202E-02 | ADORA2A, ADORA3, ADORA1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 4.055E-03 | 2.838E-02 | ADORA3, ADORA1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04022 | cGMP-PKG signaling pathway | 7.701E-03 | 3.408E-02 | ADORA3, ADORA1 |
09120 Genetic Information Processing | 09122 Translation | hsa03013 | RNA transport | 8.152E-03 | 3.408E-02 | SMN2, SMN1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 1.078E-02 | 3.775E-02 | ADORA2A, ADORA1 |
09100 Metabolism | 09104 Nucleotide metabolism | hsa00230 | Purine metabolism | 8.521E-03 | 3.408E-02 | PNP, ADK |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.464E-02 | 4.554E-02 | CDA, PNP, ADK, TK1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00760 | Nicotinate and nicotinamide metabolism | 2.296E-02 | 6.428E-02 | PNP |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Cancer | C00-C96 | TK1; ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Multiple scierosis | G35 | ADORA1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Atrial fibrillation | E78, I48 | ADORA1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TK1; CDA; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Radionuclide imaging | W88 | ADORA2A; |
I00-I99: Diseases of the circulatory system | Cardiac disease | I00-I99 | ADORA1; |
I00-I99: Diseases of the circulatory system | Cardiac arrhythmias | I47-I49 | ADORA1; |
A00-B99: Certain infectious and parasitic diseases | Adult varicella zoster virus infection | B02 | TK1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Autoimmune diabetes | E08-E13 | ADORA1; |
A00-B99: Certain infectious and parasitic diseases | Sepsis | A40, A41 | ADORA1; |
I00-I99: Diseases of the circulatory system | Arteriosclerosis | I70 | ADORA2A; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | ADORA1; ADORA2A; |
C00-D49: Neoplasms | Brain cancer | C71, D33 | TK1; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | ADORA2A; |
N00-N99: Diseases of the genitourinary system | Renal failure | N17, N18, N19 | ADORA1; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | TK1; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | ADORA2A; ADK; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | ADORA1; ADORA2A; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | ADORA1; |
I00-I99: Diseases of the circulatory system | Orthostatic hypotension | I95.1 | ADORA1; |
I00-I99: Diseases of the circulatory system | Cerebrovascular ischaemia | I61-I63 | ADORA3; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TK1; |
C00-D49: Neoplasms | Prostate cancer | C61 | TK1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Allergy | T78.4 | ADORA1; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | ADORA1; ADORA2A; |
I00-I99: Diseases of the circulatory system | Ischemia | I99.8 | ADORA3; |
L00-L99: Diseases of the skin and subcutaneous tissue | Diabetic foot ulcer | L88-L89 | ADORA2A; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ADORA3; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | ADORA1; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ADORA1; ADORA2A; ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Epileptic seizures | G40, P90, R56 | ADK; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | ADK; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Graft-versus-host disease | T86.0 | TK1; |
J00-J99: Diseases of the respiratory system | Allergic rhinitis | J00, J30, J31.0, T78.4 | ADORA2A; |
I00-I99: Diseases of the circulatory system | Heart failure | I50 | ADORA1; |
NA: NA | Hepatitis C virus infection | NA | ADORA3; |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | ADORA3; |
I00-I99: Diseases of the circulatory system | Acute and chronic heart failure | I50 | ADORA1; |
I00-I99: Diseases of the circulatory system | Coronary disorder diagnosis | I20-I25 | ADORA2A; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Convulsions | R56.0 | ADK; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hypertriglyceridemia | E78.1, E78.2, E78.3, I47-I49 | ADORA1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | ADORA1; |
I00-I99: Diseases of the circulatory system | Hypertension | I10-I16 | ADORA1; ADORA2A; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Fatigue | R53 | ADORA1; |